2001
DOI: 10.1038/sj.gt.3301340
|View full text |Cite
|
Sign up to set email alerts
|

Expression of vhs and VP16 during HSV-1 helper virus-free amplicon packaging enhances titers

Abstract: Recently developed helper virus-free methods of herpes simplex virus (HSV) amplicon vector packaging provide stocks that are virtually devoid of the cytotoxic component normally associated with traditional helper virus-based packaging methods. These approaches involve cotransfection of amplicon plasmid DNA with either a five-cosmid set or a bacterial artificial chromosome (BAC) that contains the HSV genome without its cognate pac signals. Helper virus-free amplicon packaging produces low-titer stocks (Ͻ10 5 ex… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
41
0

Year Published

2001
2001
2011
2011

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 54 publications
(41 citation statements)
references
References 32 publications
0
41
0
Order By: Relevance
“…[47][48][49][50] This packaging strategy requires the cotransfection of eucaryotic cells that are receptive to HSV propagation (ie, BHK, Vero) with packaging-incompetent HSV genomic DNA, amplicon DNA, and any accessory HSV genes shown to enhance amplicon titers. 51 Crude vector lysates are then purified by a series of ultracentrifugation steps and titered by expression or transduction-based methodologies. 52 The titers obtained from helper virus-free amplicon packaging typically range from 10 7 to 10 8 expressing virus particles/ml.…”
Section: Hsv Amplicon Vectorsmentioning
confidence: 99%
“…[47][48][49][50] This packaging strategy requires the cotransfection of eucaryotic cells that are receptive to HSV propagation (ie, BHK, Vero) with packaging-incompetent HSV genomic DNA, amplicon DNA, and any accessory HSV genes shown to enhance amplicon titers. 51 Crude vector lysates are then purified by a series of ultracentrifugation steps and titered by expression or transduction-based methodologies. 52 The titers obtained from helper virus-free amplicon packaging typically range from 10 7 to 10 8 expressing virus particles/ml.…”
Section: Hsv Amplicon Vectorsmentioning
confidence: 99%
“…Recombinant adenoviruses containing HA-Pincher and HAPincherG68E (7), T7-RacN17, EGFR, ETrkB, EGFR-GFP, Rab5-GFP, Rab7-GFP, or RacV12-GFP were made using the Ad-Easy system (Stratagene). Recombinant adenoviruses containing HSVs containing PincherG68E or GFP were packaged into helper virus-free amplicon particles (29).…”
Section: Methodsmentioning
confidence: 99%
“…HSV-1 amplicons have a transgene capacity sufficient to carry the NR2D cDNA and the coexpressed GFP reporter gene (Arvanian et al, 2004). HSV-1-gfpmediated gene expression peaks during the first 24 -48 h (Bowers et al, 2000(Bowers et al, , 2001. The motoneuron infection was determined by using double immunolabeling with peripherin (motoneurons marker, green) and with GFP (red).…”
Section: Spinal Cord Injury and Treatment Deliverymentioning
confidence: 99%
“…Packaging of helper virus-free amplicon vector stocks and subsequent virus purification and determination of amplicon virus titers via both expression-and transduction-based methodologies were performed as previously described (Bowers et al, 2000(Bowers et al, , 2001. Vectors carried genes for either NR2D (HSV-NR2D) or ␤-galactosidase (HSVlac), as well as the reporter gene green fluorescent protein (GFP).…”
Section: Hsv Amplicon Vector Construction and Packagingmentioning
confidence: 99%